Influence of Baseline HbA1c and Antiplatelet Therapy on 1-Year Vein Graft Outcome

Yunpeng Zhu,Junlong Hu,Minlu Zhang,Qing Xue,Hao Liu,Rui Wang,Xiaowei Wang,Zhaoyun Cheng,Qiang Zhao

JACC: Asia（2022）

引用 1|浏览5

暂无评分

摘要

In the DACAB trial, lower baseline HbA1c was associated with higher vein graft patency 1 year after CABG. T+A improved 1-year vein graft patency vs A, irrespective of baseline HbA1c.

查看译文

关键词

aspirin,coronary artery bypass grafting,glycated hemoglobin A,patency,ticagrelor,vein graft

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要